RP-HPLC Determination of Quercetin in a Novel D-Alpha-Tocopherol Polyethylene Glycol 1000 Succinate Based SNEDDS Formulation: Pharmacokinetics in Rat Plasma
March 2021
in “
Molecules
”
New to Quercetin? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that a new quercetin-loaded self-nanoemulsifying drug delivery system improved quercetin bioavailability by 149.8% compared to its suspension in rats.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study developed a novel self-nanoemulsifying drug delivery system (SNEDDS) to enhance the bioavailability of quercetin (QU), a flavonoid with health benefits but limited clinical use due to low bioavailability. The SNEDDS formulation, which included D-α-Tocopherol polyethylene glycol 1000 succinate, improved QU bioavailability by 149.8% compared to its suspension. The study used a new RP-HPLC method to determine QU and TPGS in rat plasma, showing high sensitivity. Key pharmacokinetic improvements included a higher Cmax, reduced Tmax, and increased AUCt. The study involved 7 rats and demonstrated that the SNEDDS formulation significantly improved QU delivery and efficacy.
